tuftsin has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Li, Y; Liu, WJ; Liu, XJ; Zhang, SH; Zhen, YS | 1 |
| Babcock, GF; Goepfert, H; Nishioka, K; Romsdahl, MM; Schantz, SP | 1 |
2 other study(ies) available for tuftsin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.
Topics: Animals; Carcinoma, Squamous Cell; CD47 Antigen; Cell Communication; Cell Line, Tumor; Down-Regulation; Enediynes; ErbB Receptors; Female; Humans; Immunotoxins; Mice; Mice, Inbred BALB C; Murine pneumonia virus; Recombinant Fusion Proteins; Tuftsin; Xenograft Model Antitumor Assays | 2014 |
The effect of surgery on natural killer cell activity in head and neck cancer patients: in vitro reversal of a postoperatively suppressed immunosurveillance system.
Topics: Aged; Carcinoma, Squamous Cell; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Head and Neck Neoplasms; Humans; Immunity, Cellular; Immunologic Surveillance; Immunosuppression Therapy; In Vitro Techniques; Killer Cells, Natural; Lymphocyte Activation; Middle Aged; Postoperative Period; T-Lymphocytes, Regulatory; Tuftsin | 1985 |